APA (7th ed.) Citation

CE, A., S, S., LMS, G., CG, S., JA, R., T, Z., . . . JJ, B. (2025). Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: The EMPATROPISM-FE trial. European heart journal, 46(16), 1507. https://doi.org/10.1093/eurheartj/ehae917

Chicago Style (17th ed.) Citation

CE, Angermann, et al. "Anaemia Predicts Iron Homoeostasis Dysregulation and Modulates the Response to Empagliflozin in Heart Failure with Reduced Ejection Fraction: The EMPATROPISM-FE Trial." European Heart Journal 46, no. 16 (2025): 1507. https://doi.org/10.1093/eurheartj/ehae917.

MLA (9th ed.) Citation

CE, Angermann, et al. "Anaemia Predicts Iron Homoeostasis Dysregulation and Modulates the Response to Empagliflozin in Heart Failure with Reduced Ejection Fraction: The EMPATROPISM-FE Trial." European Heart Journal, vol. 46, no. 16, 2025, p. 1507, https://doi.org/10.1093/eurheartj/ehae917.